Title : Radioimmunotherapy in non-Hodgkin's lymphoma: focus on 90Y-ibritumomab tiuxetan (Zevalin).

Pub. Date : 2004 Dec

PMID : 15844660






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The radioimmunoconjugate 90Y-ibritumomab tiuxetan is directed against the B-cell antigen, CD20. ibritumomab tiuxetan keratin 20 Homo sapiens